Stratis ST ACL系統(tǒng)是一種新型前十字韌帶重建系統(tǒng)，可以減少手術時間和患者的創(chuàng)傷。該系統(tǒng)已經(jīng)獲得美國食品藥品管理局的許可。

該系統(tǒng)是根據(jù)以及獲得技術設計制造的，包括使用可生物吸收聚合體材料制造的可重復使用的工具和固定植入體。系統(tǒng)允許外科醫(yī)生使用關節(jié)內窺鏡檢查操作，從而減少了手術時間和患者的創(chuàng)傷。該技術通過減少了手術步驟、免除了復雜費時的測量而將外科手術方案簡化。Stratis植入體提供了組織到骨的通道壓縮以及在股骨關節(jié)線固定，這是需要外科醫(yī)生鑒別的兩個關鍵區(qū)域，而使用當前技術無法進行鑒別。

Stratis系統(tǒng)由美國Scandius BioMedical公司(Littleton, MA, USA)研制成功，該公司目前關注重點是關節(jié)內窺鏡檢查操作進行軟組織前十字韌帶重建，未來發(fā)展將涉及關節(jié)軟骨、半月板修補以及其它運動相關性軟組織與關節(jié)損傷。

Scandius生物醫(yī)學公司創(chuàng)始人、主席、首席執(zhí)行官Mark A. Johanson說：“我們相信Stratis將為外科醫(yī)生提供手術與臨床的效益，我們十分高興將這項革新技術應用于外科醫(yī)生迫切需求改進的領域，”
 
Patented ACL Reconstruction System 
 
A new anterior cruciate ligament (ACL) reconstruction system is designed to reduce both surgical time and patient trauma. Called Stratis ST ACL, the system has been cleared by the U.S. Food and Drug Administration (FDA).

The system is based on patented technology comprising reusable instruments and a fixation implant manufactured from both bioabsorbable and polymer materials. By allowing a surgeon to perform the procedure arthroscopically, both surgical time and patient trauma are reduced. The technology simplifies the surgical procedure by reducing the number of steps needed to perform the technique while also eliminating complicated, time-consuming measurements. The Stratis implant provides tissue-to-bone tunnel compression and fixation at the joint line of the femur, two key areas of need that surgeons have identified as unmet with current technology.

Stratis was developed by Scandius BioMedical, Inc. (Littleton, MA, USA), whose current focus is on arthroscopic soft tissue ACL reconstruction, with future developments addressing the areas of articular cartilage, meniscal repair, and other soft-tissue sports-related joint injuries.

“We believe Stratis will provide surgeons both surgical and clinical benefits, and we are excited to bring an innovative technology solution in an area where surgeons have expressed a need for advancement,” said Mark A. Johanson, founder, president, and CEO of Scandius BioMedical.